Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHCPR Awards Garlic, Milk Thistle Studies To Univ. Of Texas Center

This article was originally published in The Tan Sheet

Executive Summary

The effect of garlic on cardiovascular disease and cancer prevention and Silybum marianum (milk thistle) on liver disease is being investigated by the University of Texas Health Science Center, San Antonio, under a grant from HHS' Agency for Health Care Policy & Research.

You may also be interested in...



Garlic Supplement Dissolution Standards Clinical Trial Use Suggested

Future clinical trials on garlic and cardiovascular disease should use supplements that pass U.S. Pharmacopeia dissolution standards for high allicin release, a researcher suggested at a National Institutes of Health conference June 12 in Bethesda, Md.

Garlic Supplement Dissolution Standards Clinical Trial Use Suggested

Future clinical trials on garlic and cardiovascular disease should use supplements that pass U.S. Pharmacopeia dissolution standards for high allicin release, a researcher suggested at a National Institutes of Health conference June 12 in Bethesda, Md.

Garlic Supplement Dissolution Standards Clinical Trial Use Suggested

Future clinical trials on garlic and cardiovascular disease should use supplements that pass U.S. Pharmacopeia dissolution standards for high allicin release, a researcher suggested at a National Institutes of Health conference June 12 in Bethesda, Md.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089484

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel